2012 ACR/ARHP Annual Meeting Archives

Abstract Number: 852

C-Reactive Protein Predicts Long-Term Progression of Interstitial Lung Disease and Survival in Patients with Early Systemic Sclerosis
Abstract Number: 1321

C-Type Lectin Domain Family 4, Member C Gene Expression Level Helps Predict Future Clinical Response to Tabalumab Blockade of B Cell Activating Factor in Rheumatoid Arthritis
Abstract Number: 2682

Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Systemic Lupus Erythematosus
Abstract Number: 1273

Can Response Duration After the First Rituximab Treatment Be Used in Timing of Rituximab Retreatment?
Abstract Number: 399

Can Sustained Remission of Rheumatoid Arthritis Be Predicted? an Analysis From the Japanese National Database of Rheumatic Disease (NinJa)
Abstract Number: 401

Can We Improve Outcomes in Early Rheumatoid Arthritis by Determining Best Practices? An Analysis of the Canadian Early Rheumatoid Arthritis Cohort (CATCH)
Abstract Number: 99

Cancer Iincidence and Type of Malignancy in Rrheumatologic Ddiseases in Korea: Head-to-Head Comparison
Abstract Number: 2475

Cancer in Pediatric-Onset Systemic Lupus: What Is the Role of Disease Duration and Other Factors on Risk?
Abstract Number: 1039

Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging
Abstract Number: 1198

Cardiovascular Risk Factors and Events Are More Frequent Prior to the Onset of Rheumatoid Arthritis Than in the General Population
Abstract Number: 68

Cardiovascular Comorbidities Antedating the Diagnosis of Rheumatoid Arthritis
Abstract Number: 2404

Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus and/or Antiphospholipid Antibody Positive Patients: Two-Year Preliminary Analysis of Diet and Exercise Habits
Abstract Number: 1434

Cardiovascular Morbidity in a Long-Term Follow-up Cohort of Systemic Lupus Erythematosus Patients in Southern Sweden
Abstract Number: 1246

Cardiovascular Risk Assessment in Rheumatoid Arthritis (RA) Patients Treated by Biologic Response Modifiers
Abstract Number: 2216

Cardiovascular Risk Assessment in Spondyloarthritis Using the Score Chart and Reclassification by Presence of Plaques On Ultrasonography
Abstract Number: 1720

Cardiovascular Risk Management in Rheumatoid Arthritis Is Nurse Led Intervention Effective?
Abstract Number: 1979

Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center
Abstract Number: 1263

Carotid Arterial Wall Inflammation Is Associated with a Specific Profile of Inflammatory Biomarkers and Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Patients
Abstract Number: 11

Cartilage Tissue Engineering Using Collagen Scaffolds and Human Mesenchymal Stem Cells
Abstract Number: 1120

Cartilage Volume Loss Occurs in Most Older Adults and the Rate of Loss Increases with Age
Abstract Number: 1443

Caspase-1 Modulates Endothelial Dysfunction and Vascular Repair in Murine Lupus
Abstract Number: 760

Catch-up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase 3 Clinical Trial
Abstract Number: 2194

Cathepsin S Activity in Tears As a Marker of Sjögren’s Syndrome
Abstract Number: 2428

Causal Beliefs of Disease Among Patients with Systemic Vasculitis
Abstract Number: 2295

Caveolin-1 Deficiency Induces Spontaneous Endothelial-to-Mesenchymal Transition (EndoMT) in Murine Pulmonary Endothelial Cells in Vitro
Abstract Number: 1476

Caveolin-1 Deficiency May Play a Role in the Predisposition of African Americans to SSc ILD
Abstract Number: 1661

CCR1 Potentiates Gouty Inflammation Following Initial CXCR2-Dependent Neutrophil Recruitment to Sites of Monosodium Urate Crystal Deposition in Mice
Abstract Number: 2075

CCR6⁺Foxp3⁺ Regulatory T Cells Regulate the Development of Collagen Induced Arthritis in T Cell Specific RORγt Transgenic Mice
Abstract Number: 1070

CD11c+ Dendritic Cells Play an Important Proinflammatory Role in Inflammatory Arthritis
Abstract Number: 2308

CD11c⁺ Cells Are Necessary for Myofibroblast Maintenance in Bleomycin-Induced Cutaneous Fibrosis
Abstract Number: 1064

CD1c-Expressing Myeloid Dendritic Cells From Joints of Rheumatoid Arthritis Patients Produce Increased Levels of T Cell-Attracting Chemokines and Strongly Activate Autologous T Cells
Abstract Number: 1494

CD40 Signaling Results in Microvascular Endothelial Dysfunction: A Possible Clue to the Pathogenesis of Scleroderma Vasculopathy
Abstract Number: 2503

CD8+Foxp3-CD103+ Regulatory T Cells Generated Ex Vivo with TGF-β Suppress Autoimmunity Through IL-10-Dependet Mechanism
Abstract Number: 603

Cell Bound Complement Activation Products Are Associated with Disease Activity in Systemic Lupus Erythematosus
Abstract Number: 375

Cell Phone Based Automated Monitoring of Patients with Early Rheumatoid Arthritis
Abstract Number: 686

Cell-Type Specific Type I Interferon Signatures in Autologous Stem Cell Transplanted Lupus Patients: Different Molecular Behavior Between CD4+ T Cells and Monocytes
Abstract Number: 979

Cell-Type Specific Type I Interferon Signatures in Systemic Lupus Erythematosus and Viral Infection: What Makes the Difference?
Abstract Number: 234

Central Sensitization Is Associated with Spontaneous Pain in Knee Osteoarthritis
Abstract Number: 961

Cerebral Grey and White Matter Changes in Fibromyalgia Depend On Patients’ Age
Abstract Number: 2684

Cerebrospinal Fluid IL-6 and Anti-NMDA Receptor NR2 Antibodies As Surrogate Markers for CNS Disease Severity in SLE
Abstract Number: 1319

Certolizumab Pegol Plus Methotrexate Is Similarly Effective in Active Rheumatoid Arthritis Secondary Non-Responders to Anti-TNF Inhibitors: Post-Hoc Analysis of a Phase Iiib Trial
Abstract Number: 834

Cetrorelix, a Gonadotropin-Releasing Hormone Antagonist, Significantly Reduces Tumour-Necrosis-Factor-Alpha and Demonstrates Efficacy in Patients with Active Rheumatoid Arthritis: A Proof-of-Concept, Double-Blind, Randomised Trial
Abstract Number: 2327

CGEN-15001, a Novel Negative Costimulatory Fusion Protein Is Effective in the Collagen-Induced Arthritis Mouse Model of Rheumatoid Arthritis
Abstract Number: 779

Changes in Active Inflammatory Lesions Assessed by Magnetic Resonance Imaging: Results of the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial
Abstract Number: 1276

Changes in B Cell Populations and Serum Immunoglobulins and Their Relationship to Infections in a One Year, Uncontrolled Open Label Study of Tabalumab
Abstract Number: 2512

Changes in Bone Marrow Lesion Volume Relate to Changes in Knee Pain. Data From the Osteoarthritis Initiative
Abstract Number: 1906

Changes in Gout patient´s Clinical Profile in the Last Two Decades
Abstract Number: 2624

Changes in Leisure Participation in Persons with Systemic Sclerosis
Abstract Number: 1342

Changes in Patient Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic Naive RA Subjects with Background Methotrexate) Trial
Abstract Number: 580

Changes in Sclerostin, Dickkopf-1 and Serum Markers of Inflammation, Cartilage and Bone Turnover in Patients with Axial Spondyloarthritis Treated with Adalimumab
Abstract Number: 732

Changes in Subchondral Bone Provide a Sensitive Marker for Osteoarthritis and Its Progression: Results From a Large Osteoarthritis Initiative Cohort
Abstract Number: 937

Changes in Ten Year Survival Among SLE Patients At an Academic Center in North America (1970-2011)
Abstract Number: 1336

Changes in the Levels of Anti-Cyclic Citrullinated Protein Antibody and Immunoglobulins in Rheumatoid Arthritis Patients After Administration of Tocilizumab
Abstract Number: 35

Changes in Tibial Bone and Cartilage Structure in a Mouse Surgical Model of Osteoarthritis
Abstract Number: 2126

Changes of Serological Markers in the Course of Traditional and Biological Disease Modifying Therapy of Rheumatoid Arthritis
Abstract Number: 1034

Changing Osteoarthritis Treatment Assessment Paradigms: Subchondral Bone Is a More Responsive Measure of Progression Than the Current Radiographic Standard
Abstract Number: 1035

Characterisation of New Bone Formation in Gout: A Quantitative Site-by-Site Analysis Using Plain Radiography and Computed Tomography
Abstract Number: 370

Characteristic of the Japanese Patients with Rheumatoid Arthritis (RA) of Rapid Radiographic Progression (RRP) Treated with Synthetic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Daily Practice: A Large-Scale Prospective Longitudinal Cohort Study (the 1st report of Apple Survey)
Abstract Number: 1300

Characteristics Associated with Biologic Initiation As Monotherapy Versus Combination Therapy in Patients with Rheumatoid Arthritis (RA) in a US Registry Population
Abstract Number: 1622

Characteristics of Patients with Infectious Cryoglobulinemia Vasculitis in the Absence of HCV Infection: Results From the French Nationwide Cryovas Survey
Abstract Number: 2374

Characteristics, Treatment and Outcome of Gastrointestinal Involvement in Behcet’s Syndrome: Experience in A Dedicated Center
Abstract Number: 505

Characterization of an in Vitro Model of Human Salivary Gland for Studying Sjögren Syndrome (SS)
Abstract Number: 2577

Characterization of Circulating Human B Cells That Bind Cyclic Citrullinated Peptide Antigens in Clinically Active Rheumatoid Arthritis
Abstract Number: 1401

Characterization of Clinical Photosensitivity in Cutaneous Lupus Erythematosus
Abstract Number: 516

Characterization of Dominant B- and Plasma Cell Clones in Patients with Primary Sjögren’s Syndrome and Patients with Sicca Syndrome
Abstract Number: 1671

Characterization of Jo-1 Autoantibodies in Patients with Inflammatory Myopathy and Interstitial Lung Disease
Abstract Number: 204

Characterization of Joint Disease in Mucopolysaccharidosis Type I Mice and the Effects of Enzyme Replacement Therapy
Abstract Number: 1113

Characterization of Lumbar Spine Individual Radiographic Features in African American and White Women and Men: The Johnston County Osteoarthritis Project
Abstract Number: 691

Characterization of Pro-Inflammatory Cytokines and Vitamin D Levels in a Lupus Cohort and Correlation with Disease Activity
Abstract Number: 2239

Characterization of Pure Membranous Lupus Nephritis: A Cohort of 150 Patients
Abstract Number: 1454

Characterization of Renal Mononuclear Phagocyte Populations in Murine SLE Nephritis
Abstract Number: 734

Chemokine (C-C Motif) Receptor 2 Signaling Mediates Persistent Pain in Experimental Osteoarthritis
Abstract Number: 1803

Chemokine-Like Receptor 1 (CMKLR1), a G Protein Coupled Receptor Expressed On Proinflammatory Monocytes in Arthritis, Is Negatively Regulated by GRK3
Abstract Number: 274

Childhood Onset Angiitis of the Central Nervous System: What Outcomes Can We Expect?
Abstract Number: 2535

Childhood Physical Fitness Predicts Adulthood Knee Cartilage Volume and Bone Area: A 25-Year Cohort Study
Abstract Number: 298

Childhood-Onset Predicts Increased Disease Damage and Steroid Toxicity in a Cohort of Adults with Systemic Lupus Erythematosus
Abstract Number: 306

Children with Probable SLE by ACR Criteria May Need More Aggressive Lupus Treatment Early in the Disease Course
Abstract Number: 2036

Children’s Hospital of Pittsburgh Pediatric Onset En Coup De Sabre and Parry-Romberg Syndrome Cohort
Abstract Number: 1146

Choice of Systemic JIA Treatment Among Childhood Arthritis and Rheumatology Research Alliance (CARRA) Rheumatologists
Abstract Number: 1901

Chronic Gout. Improvement According to Outcome Meaures in Rheumatology Domains in Daily Clinical Practice
Abstract Number: 2027

Chronic Nonbacterial Osteomyelitis of the Mandible in Children: a Tertiary Center Experience
Abstract Number: 435

CIP2A Facilitates Apoptotic Resistance of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis Independent of c-Myc Expression
Abstract Number: 1609

Circulating 25-Hydroxyvitamin D Level and Risk of Developing Rheumatoid Arthritis
Abstract Number: 1425

Circulating Free Protein S Levels May Be Linked to Cardiovascular Events and Venous Thrombosis in SLE
Abstract Number: 2615

Circulating Levels of Citrullinated Vimentin Fragments Are Diagnostic and Prognostic in Ankylosing Spondylitis; Evidence for Disease-Related Citrullination
Abstract Number: 2123

Circulating Mir-223 Is Associated with Disease Activity and May Predict the Response to Therapy in Treatment naïve Patients with Early Rheumatoid Arthritis
Abstract Number: 1767

Circulating Plasmablasts As a Source of Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis
Abstract Number: 2674

Cis-Expression Quantitative Trait Loci Analysis of Dysregulated Interferon-Pathway Genes Identifies HLA-C and OAS1 As Novel Candidates for Susceptibility to Sjögren’s Syndrome
Abstract Number: 737

Citrullination of ENA-78/CXCL5 Results in Conversion From a Non-Monocyte Recruiting to a Monocyte Recruiting Chemokine
Abstract Number: 1690

Citrullination within the Atherosclerotic Plaque: A New Potential Target for Anti-Citrullinated Protein Antibodies
Abstract Number: 2202

Classification Criteria for Sjögren’s Syndrome: Comparison of the Performance of the 2002 American-European Consensus Group Criteria (AECG) and the 2012 ACR Criteria
Abstract Number: L3

Classification Criteria for Systemic Sclerosis: Preliminary Results
Abstract Number: 1734

Clinical Accuracy for Diagnosis of Antiphospholipid Syndrome in Systemic Lupus Erythematosus: Evaluation of 23 Possible Combinations of Antiphospholipid Antibody Specificities
Abstract Number: 797

Clinical and Biomechanical Characteristics of Total Hip Arthroplasty Responders and Nonresponders
Abstract Number: 282

Clinical and Laboratory Features Distinguishing Juvenile Polymyositis and Muscular Dystrophy in Children
Abstract Number: 192

Clinical and Laboratory Findings in A Cohort of Italian Patients with Adult Onset Still’S Disease: The Role of IL-18 As A Disease Biomarker
Abstract Number: 1594

Clinical and Radiological Outcomes After One Year of Remission Steered Combination Treatment in Patients with Early Rheumatoid and Undifferentiated Arthritis
Abstract Number: 1598

Clinical and Serologic Predictors of Response in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) – the RIM Study
Abstract Number: 216

Clinical and Serological Associations of Malignancy in Adult Patients with Polymyositis and Dermatomyositis
Abstract Number: 1166

Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey
Abstract Number: 1370

Clinical and Ultrasonographic Features of Nail Disease in Psoriasis and Psoriatic Arthritis
Abstract Number: 1422

Clinical Associations of Anti-Smith Antibodies in Profile: A Multiethnic Lupus Cohort
Abstract Number: 1873

Clinical Characteristics and Health Care Utilization Patterns Among Patients with Fibromyalgia Newly Prescribed Amitriptyline, Duloxetine, Gabapentin or Pregabalin: A Large Cohort Study
Abstract Number: 2025

Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome
Abstract Number: 643

Clinical Characteristics for Future Development of Systemic Lupus Erythematosus in Korean Patients with Idiopathic Thrombocytopenic Purpura
Abstract Number: 1552

Clinical Correlates, Treatment Outcomes and Predictors of Vasculitis Associated with Rheumatoid Arthritis in the ‘Biologic Era’ : A Case-Control Study
Abstract Number: 700

Clinical Correlation of Flow-Mediated Endothelium-Dependent Vasodilatation in Systemic Sclerosis
Abstract Number: 1392

Clinical Correlation with Anti Double Stranded Deoxyribonucleic Acid Via Enzyme Linked Immunoassay Versus Multiplex Immunoassay
Abstract Number: 2005

Clinical Course and Outcomes of Children with Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Uveitis
Abstract Number: 203

Clinical Course Factors Associated with Outcome of Monoarthritis : A Retrospective Study of 173 Cases
Abstract Number: 229

Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies
Abstract Number: 2436

Clinical Effectiveness and Costs of an Integrated Rehabilitation Programme Compared with Outpatient Physiotherapy for Chronic Knee Pain
Abstract Number: 159

Clinical Efficacy Outcomes with up to 3 Years of Pegloticase Treatment for Refractory Chronic Gout
Abstract Number: 1941

Clinical Evaluation of Anti-Aminoacyl tRNA Synthetase Antibodies in Japanese Patients with Connective Tissue Diseases
Abstract Number: 1367

Clinical Features and Treatment Results of Japanese Patients with SAPHO (Synovitis-Acne-Pustulosis-Hyperostosis-Osteitis) Syndrome
Abstract Number: 1470

Clinical Features Associated with Anti-Th/to in Non-Scleroderma Patients – Sine Scleroderma?
Abstract Number: 912

Clinical Features Associated with Progression of Knee Radiographic Osteoarthritis: Data From the Osteoarthritis Initiative
Abstract Number: 1932

Clinical Features of an Aromatase Inhibitor Associated Syndrome Presenting As Rheumatoid Arthritis Ronald J. Anderson, MD, Brigham &Women’s Hospital
Abstract Number: 1536

Clinical Features of Patients with Anti-Neutrophil Cytoplasmic Autoantibodies Targeting Native Myeloperoxidase Antigen
Abstract Number: 62

Clinical Implication of Rheumatoid Factor Formation According to Various Hepatitis B Virus Infection Status and Vaccination
Abstract Number: 2242

Clinical Manifestations and Predictive Factors for Response to Induction Therapy and Maintenance of Remission in ISN/RPS Class V Lupus Nephritis
Abstract Number: 2265

Clinical Manifestations of Systemic Lupus Erythematosus Vary Based On Age of Disease Onset
Abstract Number: 1868

Clinical Outcome in Fibromyalgia Patients Treated with Milnacipran Is Largely Independent of Symptom Duration
Abstract Number: 1461

Clinical Outcomes of Scleroderma Patients At High Risk for Pulmonary Hypertension. Analysis of the Pulmonary Hyparternsion Assessment and Recognition of Outcomes in Scleroderma Registry
Abstract Number: 1673

Clinical Phenotypes of Caucasian Adult and Juvenile Dermatomyositis Patients with Anti-MDA5 Autoantibodies
Abstract Number: 1821

Clinical Predictors of Methotrexate-Induced Liver Enzyme Elevation in Patients with Rheumatoid Arthritis in an Electronic Medical Record
Abstract Number: 1413

Clinical Presentation, Treatment and Outcome of Membranous Nephropathy in SLE: A Comparison with Proliferative Lupus Glomerulonephritis in 141 Patients
Abstract Number: 446

Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Rheumatoid Arthritis Patients
Abstract Number: 1312

Clinical Response At 12 Weeks Predicts Long-Term Remission and the Extent of Radiographic Progression in Japanese Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol with and without Methotrexate Coadministration
Abstract Number: 2558

Clinical Response, Drug Survival and Predictors Thereof Among 548 Switchers of Tumor Necrosis Factor Alpha Inhibitor Therapy in Psoriatic Arthritis. Results From the Danish Nationwide Danbio Registry
Abstract Number: 836

Clinical Responses and Patient Reported Outcomes to NNC0109-0012 (anti-IL-20 mAb) in Rheumatoid Arthritis (RA) Patients Following 12-Weeks Dosing and 13 Weeks Follow up: Results From a Phase 2a Trial
Abstract Number: 209

Clinical Study of Determination of Myositis-Associated Autoantibodies in Japanese Patients with Connective Tissue Diseases except Autoimmune Myositis
Abstract Number: 292

Clinical Utility of Anti-CADM-140/Melanoma Differentiation-Associated Gene 5 Autoantibody Titers in Patients with Juvenile Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
Abstract Number: 2402

Clinical Utility of the Hospital Anxiety and Depression Scale for an Outpatient Fibromyalgia Education Program
Abstract Number: 650

Clinical Variables Associated with Thrombosis At Systemic Lupus Erythematosus Diagnosis. Differences Between Patients with Positive/Negative Lupus Anticoagulant
Abstract Number: 206

Clinical, Laboratory, and Cellular Responses in the Rituximab in Myositis Trial in Patients Enrolled At the National Institutes of Health
Abstract Number: 2550

Clinical, Radiographic, and Immunogenic Effects After 1 Year of Tocilizumab-Based Treatment Strategy with and without Methotrexate in Rheumatoid Arthritis: The ACT-RAY Study
Abstract Number: 255

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
Abstract Number: 2552

Clinically Significant and Biopsy-Documented Renal Involvement in Primary Sjögren’s Syndrome: Clinical Presentation and Outcome
Abstract Number: 305

Clinicopathologic Correlates for Activity and Damage of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1137

Clinimetric Properties of a New Outcome Measure:the Hand-Osteoarthritis Aesthetic Damage Index
Abstract Number: 1918

Cluster Analysis of Organ Involvements Patients with Serum IgG4 Elevation; IgG4–related Disease Is a Distinct Subtype of Patients with Hyper-IgG4
Abstract Number: 1554

Clusters of Fatigue- a Comparison Between Persons with Systemic Lupus Erythematosus and Age and Gender Matched Controls
Abstract Number: 1001

CNstream2: Improved SNP and CNV Genotyping Reveals New Loci Associated with Rheumatic Diseases
Abstract Number: 134

Co-Existence of Gout in Rheumatoid Arthritis: It Does Happen! A Population Based Study
Abstract Number: 661

Co-Localization of C-Reactive Protein, Immunoglobulin G and Complement in Renal Subendothelial Immune Deposits of Proliferative Lupus Nephritis Detected Using Immunogold Electron Microscopy
Abstract Number: 1322

Coadministration of ASP015K, a Novel Janus Kinase Inhibitor with Methotrexate Demonstrates Tolerability and Lack of Pharmacokinetic Interactions in Patients with Rheumatoid Arthritis
Abstract Number: 952

Cognitive Behavioral Therapy and Milnacipran in Combination Appears to Be More Efficacious Than Either Therapy Alone
Abstract Number: 1878

Cognitive Manifestations of Fibromyalgia and Lupus
Abstract Number: 2003

Colchicine As a Therapeutic Option in Periodic Fever Aphtous Stomatitis, Pharingitis Syndrome. and Cervical Adenitis (PFAPA)
Abstract Number: 165

Colchicine Is Associated with a Decreased Rate of Myocardial Infarction in Gout Patients: Interim Results From a Retrospective Cohort Study
Abstract Number: 1912

Colchicine, As Assessed by Target Joint Pain Scores, Is Effective At 16 Hours in Patients with Acute Gout Flares
Abstract Number: 197

Collapsing Glomerulopathy in Collagen Vascular-Like Disease
Abstract Number: 901

Colony-Stimulating Factor (CSF) Receptor 1 Blockade Overcomes Overlapping Effects of M-CSF and Interleukin-34 On Myeloid Differentiation and Gene Expression to Reduce Inflammation in Human and Murine Models of Rheumatoid Arthritis
Abstract Number: 2390

Color Doppler Ultrasonography an Alternative to CT/MR Angiography for Identifying Large Vessel Involvement in Giant Cell Arteritis?
Abstract Number: 118

Colour Doppler Sonography of the Knee Joint: A Useful Tool to Discriminate Arthritis From Osteoarthritis ?
Abstract Number: 445

Combination of Intra-Articular Steroid Injection and Infliximab More Effective Than Infliximab in Rapid Radiographic Progression Patients with Rheumatoid Arthritis: A Randomized, Open Label, x Ray Reader Blinded Study
Abstract Number: 1645

Combination of Isoniazid for Latent Tuberculosis with Traditional and/or Biologic Disease Modifying Anti-Rheumatic Drugs Is Well Tolerated in Patients with Rheumatic Diseases
Abstract Number: 2112

Combination of Magnetic Resonance Imaging (MRI)-Proven Osteitis with 2010 RA Classification Criteria Improves the Diagnostic Probability of Rheumatoid Arthritis (RA)
Abstract Number: 1414

Combination of Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis: A 12-Month Open-Labeled Trial
Abstract Number: 2074

Combined Effects of a c-Fos/AP-1 Inhibitor T-5224 and Methotrexate On Collagen-Induced Arthritis in Mice
Abstract Number: 1135

Combined Glucosamine and Chondroitin Sulfate, Once of Three Times Daily, Provide Clinically Relevant Analgesia in Knee Osteoarthritis
Abstract Number: 1040

Combined High-Resolution Single Photon Emission Computed Tomography and Magnetic Resonance Imaging for Therapy Monitoring in Rheumatoid Arthritis
Abstract Number: 92

Combined Response Index in Diffuse Systemic Sclerosis (CRISS)—Which External Anchors to Use When Developing the Index? Baseline Analysis
Abstract Number: 105

Combined Synovial and Structural Ultrasound Score for the Diagnosis of RA
Abstract Number: 1636

Commensal Gut-Derived Bacteria As Therapy for Systemic Autoimmune Disease
Abstract Number: 2183

Common Features in Lymphoproliferative Complications in the Course of Primary Sjögren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients
Abstract Number: 77

Comorbid Conditions Do Not Explain Divergent Patient Assessments of Disease Activity and Global Health in Patients with Rheumatoid Arthritis
Abstract Number: 2171

Comparative Efficacy of Biologics As Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with an Inadequate Response to Conventional Dmards: A Network Meta-Analysis
Abstract Number: 1531

Comparative Proteomic Analysis of Neutrophils Between Microscopic Polyangiitis and Granulomatosis with Polyangiitis
Abstract Number: 1983

Comparative Risk of Fracture in Men and Women with Human Immunodeficiency Virus
Abstract Number: 953

Comparative Symptom Severity of Patients Satisfying Chronic Widespread Pain and Fibromyalgia Criteria
Abstract Number: 1814

Comparing Clinical Characteristics and Comorbidities of Gout Patients Treated with Allopurinol or Febuxostat
Abstract Number: 110

Comparing Palmar and Dorsal Ultrasound Assessment of Small Joint Synovitis in Rheumatoid Arthritis: Dorsal Greyscale Mode Yields Significantly Better Concordance with Power Doppler
Abstract Number: 604

Comparing the ACR and the SLICC Criteria for the Classification of SLE Patients Using Data from an Existing Multi-Ethnic Cohort
Abstract Number: 547

Comparison and Validation of Screening Questionnaires for Psoriatic Arthritis in Patients with Psoriasis
Abstract Number: 1126

Comparison between Osteoartritis Initiative and CHECK study (Cohort Hip & Cohort Knee); Development of pain and function during 4 years follow-up
Abstract Number: 1123

Comparison of Anatomic Knee Alignment On Physical Examination and Radiographs
Abstract Number: 129

Comparison of Automated, Computer-Based Assessment and Visually Assessed Disease Activity Scores in ICG-Enhanced Fluorescence Optical Imaging in Patients with Rheumatic Disorders: A Feasibility Study
Abstract Number: 1464

Comparison of Baseline Characteristics of the Combined Response Index for Systemic Sclerosis (CRISS) Cohort to Patients Enrolled in Clinical Trials of Diffuse Systemic Sclerosis
Abstract Number: 1616

Comparison of Conventional and Wholebody Magnetic Resonance Imaging for Assessing Inflammation and Structural Damage in Psoriatic Arthritis and Axial Spondyloarthritis
Abstract Number: 53

Comparison of Decision Rules for Identifying Patients with Rheumatoid Arthritis (RA) in Administrative Healthcare Databases
Abstract Number: 495

Comparison of Discontinuation Rates by Biologic Since 1998 in US Patients with Rheumatoid Arthritis
Abstract Number: 1327

Comparison of Four Different Intensive Treatment Strategies in Patients with Early Rheumatoid Arthritis in Korea
Abstract Number: 695

Comparison of Intense Pulsed Light and Laser Treatment of Telangiectases in Systemic Sclerosis
Abstract Number: 2249

Comparison of Mycophenolate Mofetil and Intravenous Cyclophosphamide As Induction Therapy in Korean Patients with Lupus Nephritis
Abstract Number: 484

Comparison of Rheumatoid Arthritis-Related Health Care Resource Use and Comorbidities Among Patients with Rheumatoid Arthritis Treated with Adalimumab Vs. Etanercept
Abstract Number: 1359

Comparison of Sacroiliac MRI Evaluation Versus Sacroiliac x-Rays in Peripheral Psoriatic Arthritis: Evidence of Silent Disease and Lack of Association to HLA-B27
Abstract Number: 646

Comparison of the Lupusqol and SF-36 Scores As Valid Measures of Change in Health Related Quality of Life
Abstract Number: 1346

Comparison of Three Screening Tools in Psoriatic Arthritis: The Contest Study
Abstract Number: 500

Comparison of Tolerability Between Tumor Necrosis Factor-Inhibitors and Tocilizumab for the Treatment of Rheumatoid Arthritis
Abstract Number: 1913

Complete Tophus Response in Patients with Chronic Gout Initiating Pegloticase Treatment
Abstract Number: 115

Composite Ultrasound Score in Spondyloarthropathies
Abstract Number: 182

Comprehensive Analysis of Protein Expression in Peripheral Blood Mononuclear Cells From Patients with Behcet’s Disease
Abstract Number: 430

Comprehensive Microrna Analysis Identifies Mir-24, Mir-26a, and Mir-125a-5p As Plasma Biomarkers for Rheumatoid Arthritis
Abstract Number: 869

Concepts Which Determine Health in a Positive Way Are Important to People with Rheumatoid Arthritis and Are Covered by Some Patient-Reported Outcome Instruments
Abstract Number: 470

Concomitant Assessment of Clinical and Ultrasound Efficacy and Safety of Tocilizumab in Patients with Moderate to Severe Rheumatoid Arthritis: The Torpedo Study
Abstract Number: 2181

Concomitant Atheosclerosis and Impaired Bone Health in Patients with Primary Sjogren’s Syndrome
Abstract Number: 1101

Condroitin Sulfate Decreases Chemokine Levels and Synovitis in knee osteoarthritis Patients
Abstract Number: 2303

Confirmation of TNIP1 As a Susceptibility Locus for Systemic Sclerosis in a Large Multicentre Study
Abstract Number: 2590

Consolidating Knowledge, Comprehension, Application and Analysis in Rheumatology Education by Use of an in-House Electronic Module (Web-based Rheumatology Case Scenarios)
Abstract Number: 2609

Construct and Criterion Validity of Several Proposed DAS28 Based Rheumatoid Arthritis Flare Criteria: A Cohort Validation Study
Abstract Number: 913

Consultation Prevalence of Osteoarthritis in Southern Sweden
Abstract Number: L4

Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
Abstract Number: 2137

Contribution of Disease Activity, Joint Damage and Comorbidity to Impairment (SOFI) and Disability (HAQ) in Rheumatoid Arthritis Patients Over 20 Years
Abstract Number: 1993

Contribution of Lifestyle Factors to Healthy-Adherer Bias in Prevalent Users of Osteoporotic Drugs
Abstract Number: 1228

Contributions of Inflammation, Inactivity, and Low Dose Prednisone Use to Skeletal Muscle Insulin Resistance in Well-Controlled Rheumatoid Arthritis
Abstract Number: 625

Control of Hypertension and Hypercholesterolemia Is Not Associated with a Decreased Rate of Atherosclerotic Vascular Events in Patients with Systemic Lupus Erythematosus
Abstract Number: 2180

Coronary Flow Reserve and Asymmetric Dimethylarginine Levels: New Measurements for Identifying Subclinical Atherosclerosis in Patients with Primary Sjögren’s Syndrome
Abstract Number: 1795

Correction for Basophil and Monocyte Frequencies Identifies Specific Gene Expression Differences Associated with SLE Disease Flare: Interim Report From the Bold (Biomarkers of Lupus Disease) Study
Abstract Number: 1969

Correction of Vitamin D Insufficiency with the Fixed Daily Combination Strontium Ranelate 2 g/Vitamin D₃ 1000 IU Over 12 Months
Abstract Number: 545

Correlates of Inflammatory Back Pain in a Nationally Representative Sample of the US Population
Abstract Number: 1509

Correlates of Skin Gene Expression Profile in Systemic Sclerosis
Abstract Number: 2314

Correlation Between Abatacept and Rheumatoid Factor – Can Rheumatoid Factor Be a Predictive Factor for Abatacept?
Abstract Number: 116

Correlation Between Clinical and Ultrasonographic Examination of the Calcaneal Enthesis in Patients with Ankylosing Spondylitis: A Controlled Study
Abstract Number: 2351

Correlation Between Hypoechoic Halo of the Temporal Arteries and Clinical, Laboratory, and Temporal Artery Biopsy Findings in Patients with Giant Cell Arteritis
Abstract Number: 2658

Correlation Between Mefv Genotype and Interleukin (IL)1β secretion and Role of the nlr Family Pyrin Domain Containing 3 (Nlrp3) Inflammasome in Patients with Familial Mediterranean Fever (FMF)
Abstract Number: 2162

Correlation of A Multi-Biomarker Disease Activity (VECTRA™ DA) Score with Clinical Disease Activity and Its Components with Radiographic Progression in Rheumatoid Arthritis Patients Treated with Tofacitinib
Abstract Number: 2159

Correlation of a Multi-Biomarker Disease Activity Response Assessment to Disease Activity Score 28 (C-Reactive Protein) Response Assessment and Omeract Ramris Scores in a Placebo-Controlled Rheumatoid Arthritis Clinical Trial with Abatacept (ASSET)
Abstract Number: 684

Correlation of Signal Transducers and Activators of Transcription-1 and Microrna-146a with Anaemia and Other Clinical Features in Systemic Lupus Erythematosus Patients
Abstract Number: 91

Correlations of Single Item Health Literacy Screening Questions with Established Measures of Health Literacy in Subjects with Rheumatoid Arthritis
Abstract Number: 2349

Corticosterois Therapy Restaured Treg/Th17 Balance in Patients with Polimyalgia Rheumatica
Abstract Number: 1718

Cost Effectiveness of Nurse-Led Care for People with Rheumatoid Arthritis: A Multicentre RCT
Abstract Number: 1829

Cost of Etanercept, Adalimumab, and Infliximab in Patients with Rheumatoid Arthritis with Employer Provided Health Insurance
Abstract Number: 1168

Cost-Effectiveness Analysis of Early Biologic Treatment in Polyarticular Juvenile Idiopathic Arthritis
Abstract Number: 2637

Cost-Effectiveness and Cost-Utility Analysis of Treat-to-Target Versus Usual Care in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Registry
Abstract Number: 1966

Cost-Effectiveness of Bazedoxifene Compared with Raloxifene in the Treatment of Postmenopausal Osteoporotic Women
Abstract Number: 2461

Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis
Abstract Number: 2646

Cost-Effectiveness of Tai Chi Mind-Body Exercise for the Treatment of Fibromyalgia
Abstract Number: 2463

Cost-Effectiveness of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
Abstract Number: 2509

Cost-Effectiveness of Training Rural Providers to Perform Joint Injections
Abstract Number: 2464

Cost-Sharing and Utilization of Biologic and Non-Biologic Dmards Among U.S. Medicare Beneficiaries with Rheumatoid Arthritis
Abstract Number: 386

Costs of Tumor Necrosis Factor Blockers Per Treated Rheumatoid Arthritis Patient Using Real-World Drug Data in a US Managed Care Population
Abstract Number: 1647

Critical Management Decisions in Cardiac Neonatal Lupus: The Role of Fluorinated Steroids
Abstract Number: 1510

Critical Role of the Adhesion Receptor Dnax Accessory Molecule-1 (DNAM-1) in the Development of Inflammation-Driven Dermal Fibrosis in Mouse Model of Systemic Sclerosis
Abstract Number: 2236

Cross Cultural Validation of English and French Versions of a Disease Specific Patient Reported Outcome Measure for Lupus in Canada
Abstract Number: 2537

Cross-Sectional and Longitudinal Associations Between Circulating Leptin and Knee Cartilage Thickness in Older Adults
Abstract Number: 2013

Cross-Sectional and Longitudinal comparison of Bone Mass Status, Using pQCT, in a Large Cohort of Juvenile Idiopathic Arthritis and Juvenile Onset Systemic Lupus Erythematosus Patients
Abstract Number: 2364

CROSS-Sectional Assessment of Damage in Takayasu Arteritis with A Validated Tool
Abstract Number: 786

Crosstalk Between Integrins and TGFβ in the Pathogenesis and Treatment of Multiple Presentations of Scleroderma
Abstract Number: 1439

CTL-Promoting Effects of IL-21 Results in B Cell Elimination and Disease Improvement in a Murine Model of Lupus
Abstract Number: 1679

Cumulative Long-Term Safety and Efficacy of Abatacept in Children with Juvenile Idiopathic Arthritis: Results up to 7 Years of Follow-up
Abstract Number: 1103

Cumulative Occupational Physical Load As Risk Factor for Knee Osteoarthritis
Abstract Number: 1161

Current Evidence of Anti-TNFα Treatment Efficacy in Childhood Chronic Uveitis: A Systematic Review and Meta-Analysis Approach Comparing the Different Drugs
Abstract Number: 2389

Cutaneous Leukocytoclastic Angiitis: Study of 173 Patients
Abstract Number: 758

Cutaneous Ulceration in Dermatomyositis: Association with MDA-5 and Interstitial Lung Disease
Abstract Number: 1548

Cutaneous Vasculitis as a Paraneoplastic Syndrome
Abstract Number: 960

Cyclobenzaprine (CBP) and Its Major Metabolite Norcyclobenzaprine (nCBP) Are Potent Antagonists of Human Serotonin Receptor 2a (5HT2a), Histamine Receptor H-1 and á-Adrenergic Receptors: Mechanistic and Safety Implications for Treating Fibromyalgia Syndrome by Improving Sleep Quality
Abstract Number: 665

Cytokines and Their Relation to Autoantibodies Before Disease Onset in Systemic Lupus Erythematosus